PharmaShots | Incisive News in 3 Shots

Subscribe Now

Congenital Athymia

Enzyvant Reports FDA's Acceptance of BLA for RVT-802 to Treat Pediatric Congenital Athymia

Enzyvant Reports FDA's Acceptance of BLA for RVT-802 to Treat Pediatric Congenital Athymia

June 6, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us